The global migraine drug market is estimated to grow at a CAGR of 4.8% during the forecast period. Migraine is a neurological disorder that causes multiple symptoms. Intense and debilitating headaches frequently identify it. Symptoms may include nausea, sensitivity to light and sound, vomiting, difficulty speaking, and numbness or tingling. Migraine can be diagnosed based on clinical history, reported symptoms, and by ruling out other causes. Migraine can be majorly classified into without aura (common migraines) and those with aura (classic migraines). Migraines can occur in childhood or may not reoccur until early adulthood. Women are more prone than men to have migraines. Family history is one of the most common risk factors for having migraines.

Top Driver: Growing Awareness Regarding Migraine and Various Treatments Available

The growing awareness regarding migraine and various treatments available are the significant factors driving the growth of the global migraine drugs market. Several organizations, including the American Headache and Migraine Association, are encouraging and promoting awareness about migraines and hence introducing programs and providing support to patients to make them aware of disorders related to a headache. Due to the rising number of migraine incidences and the increasing number of unmet needs in the global migraine drugs market, many market players are investing in the migraine drugs R&D. This, in turn, is estimated to drive the global migraine drugs market growth during the forecast period.

Abortive Medicine Accounts for the Largest Market Share

The global migraine drugs have been segmented into abortive medicine and preventive medicine based in the type.  Abortive medicine is the dominating segment and is estimated to continue the trend during the forecast period. On the basis of route of administration, the market has been segmented into oral, injection, and others. On the basis of distribution channel, the market is segmented into hospital-based pharmacies, retail pharmacies, and online pharmacies.

 Increasing Incidence of Migraines and Growing Public Awareness of the Disease to Benefit Asia Pacific Market

The Asia Pacific is estimated to dominate the global migraine drug market and is further expected to dominate in the near future. The growth is attributed to the increasing incidence of migraines and growing public awareness of the disease in this region. In addition to this, China and India are the major emerging countries contributing to the global migraine drug market growth in the Asia Pacific region. This is majorly due to the high occurrence of migraines in these countries. Growing focus on niche products and their launches, along with high penetration of novel drug manufacturers, will further have a positive impact on the growth of the global migraine drugs market during the forecast period.

Players to Focus on Geographical Expansion and Product Launch

The global migraine drugs market is estimated to stay fragmented during the forecast period owing to the possible new entrants. Major players are focusing on various strategic initiatives such as merger & acquisition, new product launch, geographical expansion, and increasing R&D expenditure to stay competitive in the market. Major market players operating are Endo, Allergan, Impax Laboratories, Glaxo Smith Kline, Astellas, Amgen, Bayer, AstraZeneca, Dr. Reddy’s Laboratories, Zogenix, CoLucid, Eli Lilly, Eisai, IntelGenx, Ethypharm, and Klaria. Other key players dominating the global market are Johnson & Johnson, Luitpold Pharmaceuticals.

Intel: In 2019, Allergen Company announced that a New Drug Application for UBRELVY for the acute treatment of migraines with or without aura in adults. This drug was approved by the Food and Drug Administration (United States). This acquisition will affect the growth of the market in the future.

Scope of the Report

By Type

• Abortive medicine
• Preventive medicine

By Rout of Administration

• Oral
• Injection
• Others

By Distribution Channel

• Hospital-based pharmacies
• Retail pharmacies
• Online pharmacies

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.